EARNINGS: ValiRx says trading "challenging"; Mindflair swings to loss
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Price | 0.525p on 07-10-2025 | at 18:40:08
---|---|
Change | 0.00p 0% |
Buy | 0.55p |
Sell | 0.50p |
Last Trade: | Sell 3,663.00 at 0.50p |
Day's Volume: | 333,306 |
Last Close: | 0.525p |
Open: | 0.525p |
ISIN: | GB00BLH13C52 |
Day's Range | 0.525p - 0.525p |
52wk Range: | 0.39p - 2.25p |
Market Capitalisation: | £1.97m |
VWAP: | 0.532699p |
Shares in Issue: | 374.35m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
ValiRx (VAL) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 3,663 | 0.50p | Ordinary |
15:48:46 - 07-Oct-25 |
Sell* | 26 | 0.50p | Ordinary |
15:23:45 - 07-Oct-25 |
Sell* | 554 | 0.50p | Ordinary |
15:23:23 - 07-Oct-25 |
Buy* | 309 | 0.55p | Ordinary |
14:56:46 - 07-Oct-25 |
Sell* | 12,104 | 0.50p | Ordinary |
13:58:13 - 07-Oct-25 |
Buy* | 181 | 0.55p | Ordinary |
13:14:53 - 07-Oct-25 |
Buy* | 82,604 | 0.5375p | Ordinary |
12:54:34 - 07-Oct-25 |
Sell* | 20,652 | 0.50p | Ordinary |
11:59:47 - 07-Oct-25 |
Sell* | 5,832 | 0.50p | Ordinary |
09:07:52 - 07-Oct-25 |
Buy* | 23,000 | 0.5375p | Ordinary |
09:03:01 - 07-Oct-25 |
ValiRx (VAL) Regulatory News |
||
Date | Source | Headline |
---|---|---|
29th Sep 2025 7:00 am | RNS | Half-year Report |
18th Sep 2025 7:00 am | RNS | Inaphaea Commercial Update |
1st Sep 2025 7:00 am | RNS | Cytolytix Commercial update |
26th Aug 2025 7:00 am | RNS | Commercial update |
7th Aug 2025 10:51 am | RNS | ValiRx Awarded Grant from Open University |
5th Aug 2025 9:53 am | RNS | Update on Evaluation Agreement with Stingray Bio |
4th Aug 2025 7:00 am | RNS | Licensing Agreement with Dominion Biotech Ltd |
29th Jul 2025 7:00 am | RNS | Collaboration Agreement with Voxcell BioInnovation |
30th Jun 2025 3:48 pm | RNS | Result of AGM |
20th Jun 2025 7:00 am | RNS | Ambrose Exercise Option on VAL401 |